Does UnitedHealthcare Cover Wegovy and Zepbound? UHC GLP-1 Coverage in 2026

Does UnitedHealthcare cover GLP-1s for weight loss?

Only if your plan includes weight-loss drugs, and most UnitedHealthcare plans don’t. UnitedHealthcare calls its weight-loss coverage “an optional program that is put in place for clients or businesses that have elected to cover weight loss products”. That line opens its own prior authorization policy, effective October 1, 2026.

Its notice to members about the January 1, 2027 drug list is even more direct: “Weight loss medications are excluded from coverage under most benefit plans.” So for most people with UnitedHealthcare through work, the first question is whether the employer bought that add-on. If it didn’t, a doctor’s request won’t change the answer.

Two exceptions matter. Plans that exclude weight-loss drugs can still cover Wegovy or Zepbound for other conditions, which we cover below. And some fully insured plans in a few states fall under state rules that require weight-loss drug coverage.

Which GLP-1s does UnitedHealthcare cover?

On plans with the weight-loss add-on, UnitedHealthcare’s policy lists Wegovy injection, Wegovy HD, Zepbound and the Foundayo pill. Older drugs such as Saxenda, Qsymia, Contrave and phentermine are on the list too. The Wegovy pill is the exception: the policy notes that “Wegovy tablets are typically excluded from coverage.”

When the Advantage list drops the Wegovy pill in January 2027, UnitedHealthcare names Wegovy injection, Zepbound, Qsymia and liraglutide as the covered alternatives, again only on plans that don’t exclude weight-loss drugs.

What are UnitedHealthcare’s prior authorization rules for Wegovy and Zepbound?

For weight loss, you need a BMI of 30 or more, or 27 or more with a weight-related condition, and the drug has to be part of a lifestyle plan. The condition can be high cholesterol, high blood pressure, type 2 diabetes or sleep apnea.

The lifestyle part is looser than at some insurers. UnitedHealthcare asks that the drug be “an adjunct to lifestyle modification”, such as calorie restriction, exercise, behavioral support or a community program. It doesn’t set a minimum number of months in a program before you start. Aetna, by comparison, asks for 6 months.

Age matters too. Wegovy injection can be approved from age 12. Zepbound, Foundayo and the Wegovy pill need you to be older than 16.

Does UnitedHealthcare cover Wegovy or Zepbound for other conditions?

Yes, and these uses can apply even on plans without the weight-loss add-on. UnitedHealthcare’s policy points to separate “nonformulary” criteria for plans that don’t cover weight-loss drugs.

• Wegovy can be covered to lower heart attack and stroke risk in people with established heart disease, such as a past heart attack, stroke or peripheral artery disease.
• Wegovy injection can be covered for MASH, a fatty liver disease, with moderate to advanced fibrosis (stages F2 or F3). There’s no BMI requirement for that use.
• Zepbound can be covered for moderate to severe obstructive sleep apnea.

If one of these fits you, tell your doctor. It changes which rules the request goes under.

Are the rules different in some states?

In a few states, yes. Since October 1, 2026, UnitedHealthcare has run a separate “regulatory” weight-loss program for certain fully insured plans in California, New Mexico, New York and North Dakota, where state rules require coverage. Its California HMO policy, effective the same day, says self-injectable weight-loss drugs “are covered when medically necessary under the medical benefit”, and it names Wegovy and Zepbound as examples.

The New Mexico and North Dakota rules apply to small-group and individual plans. State insurance rules generally don’t apply to self-funded employer plans, so it matters which kind you have. If you’re not sure, ask HR whether your plan is “fully insured” or “self-funded”.

Medicaid goes the other way in Massachusetts. From July 3, 2026, UnitedHealthcare Community Plan of Massachusetts stopped covering Wegovy, Zepbound and other weight-loss drugs to follow MassHealth rules. They’re still covered there for type 2 diabetes, heart disease or sleep apnea.

How do I check my own UnitedHealthcare coverage?

Start with the drug search in the UnitedHealthcare app or on myuhc.com, then ask HR one question.

1. Sign in and search for Wegovy, Zepbound or Foundayo. The result shows whether your plan covers it and what you’d pay.
2. If it shows as excluded or not covered, ask HR whether the plan includes weight-loss drug coverage. That’s the add-on UnitedHealthcare’s policy describes.
3. If it’s covered, ask your doctor to send the prior authorization with your BMI, any weight-related conditions and a note on your diet and activity plan.
4. If you’re denied, ask for the reason in writing. A BMI or paperwork problem can be fixed. An excluded benefit usually can’t, unless one of the other conditions above applies.

Does UnitedHealthcare Medicare cover Wegovy or Zepbound?

Not for weight loss alone. People with Medicare drug coverage can use Medicare’s separate GLP-1 Bridge, which charges $50 a month and runs outside UnitedHealthcare’s Part D plans.

UnitedHealthcare explained how the Bridge works in an August 11, 2026 notice to doctors:

• It covers Foundayo, Wegovy (injection and pill) and the Zepbound KwikPen. The single-dose Zepbound pen and vials aren’t included, and neither are Ozempic, Rybelsus, Mounjaro or Trulicity.
• Your doctor writes “Send to bridge for weight management” on the prescription and adds an obesity diagnosis code. Without that note, the pharmacy may bill your Part D plan, which usually won’t cover it.
• The first claim is returned on purpose, which starts the prior authorization. A decision comes within 72 hours, and later refills don’t need a new approval unless you switch drugs.
• You need a Part D plan, be 18 or older, and have a BMI of 35 or more, or 30 or more with heart failure (HFpEF), uncontrolled high blood pressure or stage 3a kidney disease. UnitedHealthcare’s notice also lists BMI 27 or more with qualifying conditions such as prediabetes.

If you already get a GLP-1 through Part D for diabetes, sleep apnea, MASH or heart disease, the Bridge doesn’t apply. Medicare’s own drug coverage page explains how Part D works.

What can I do if UnitedHealthcare won’t pay?

You can use a telehealth provider that bills UnitedHealthcare for the visits, pay cash for a brand-name drug, or look at compounded versions.

• Found takes UnitedHealthcare in most of the states it serves. On October 26, 2026, Found’s insurance page showed UnitedHealthcare in 38 of its 42 state panels; it wasn’t listed for Idaho, Kansas, Maryland or Utah. Insurance covers Found’s visits and program, while the drug still runs through your pharmacy benefit. Read our Found review.
• Several telehealth providers sell the Wegovy pill and other brand-name GLP-1s for cash. See GLP-1 cost without insurance for every channel.
• Compounded semaglutide or tirzepatide costs less, from about $99 a month month-to-month, but it isn’t FDA-approved. The FDA explains its concerns. Compare compounded GLP-1 prices or read FDA-approved vs. compounded GLP-1s.

How does UnitedHealthcare compare with Aetna?

The biggest difference is the starting rule. Aetna asks for 6 months in a weight management program before it approves a GLP-1, while UnitedHealthcare asks only that the drug be part of a lifestyle plan. Both use the same BMI thresholds and both want 5% weight loss for renewal. UnitedHealthcare’s first approvals are shorter, though: 5 to 6 months against Aetna’s 6 to 8. Read our Aetna GLP-1 coverage guide for its drug lists.